Oxford BioMedica

Company

About

Corporation
Organization
Thing
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It was established in 1995 as a spin out from Oxford University.
Oxford BioMedica
Definition
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It was established in 1995 as a spin out from Oxford University.
Oxford BioMedica
Oxford BioMedica
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It was established in 1995 as a spin out from Oxford University.

Mentions

Enter Synthace, the startup developing Antha, a language and software platform specifically for biology. In 2018, the company raised a £26 million series B round led by Horizons Ventures, to continue to develop their cloud software platform. With clients and partners such as Microsoft, Merck, Oxford Biomedica, LabGenius and Princeton, the company is fast becoming the pioneer in so-called "Computer-Aided Biology."

See also

See also: